IQuest Enterprises Private Limited entered into a definitive agreement to acquire API operations of Viatris in India on October 1, 2023. The operations include a total of six large scale API manufacturing facilities, three each in Vizag and Hyderabad, a R&D facility in Hyderabad and third-party API sales. Definitive agreements for Active Pharmaceutical Ingredients (API) and Women's Healthcare business reflect gross proceeds of up to approximately $1.2 billion (INR99.6 billion). The transaction is subject to regulatory approvals. The transaction is expected to close in Q1 2024. Mark I. Greene, Aaron M. Gruber and Andrew M. Wark, J. Leonard Teti II, Kiran Sheffrin, Jonathan J. Katz, David J. Kappos, Margaret T. Segall, Nicole M. Peles, Matthew Morreale, Joyce Law, Brian M. Budnick and Anthony J. Grisafi of Cravath, Swaine & Moore LLP and Mohit Saraf, Bikash Jhawar, Nipun Vaid, Akshayy S Nanda, Sahil Arora, Amit Gupta and Akshay Jain of Saraf & Partners acted as legal advisors, PricewaterhouseCoopers LLP acted as an accountant and Jefferies International Limited acted as a financial advisor to Viatris.

IQuest Enterprises Private Limited completed the acquisition of API operations of Viatris in India on June 3, 2024.